This document discusses extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT). ECMO provides cardiopulmonary support for critically ill patients, while CRRT manages fluid overload and acute kidney injury. The document outlines some of the technical considerations for combining ECMO and CRRT treatment, including using separate circuits or incorporating CRRT into the ECMO circuit. Some benefits of the combined treatment are managing fluid overload, electrolyte imbalances, and removing inflammatory cytokines. Early initiation of CRRT is recommended to improve outcomes in ECMO patients. Complications can include bleeding risks from anticoagulation and electrolyte disturbances.
1. Extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) are important life support therapies used in intensive care units.
2. ECMO uses an external circuit to oxygenate blood and remove carbon dioxide, functioning as a bridge to recovery, transplant, or decision. CRRT slowly removes waste and fluid from the blood of patients with kidney failure or injury.
3. The document discusses the principles, indications, techniques, and complications of ECMO and CRRT, highlighting their roles in supporting critically ill patients with cardiac, respiratory, or renal issues.
This document discusses the principles and molecular transport mechanisms of continuous renal replacement therapy (CRRT), including ultrafiltration, diffusion, convection, and adsorption. Ultrafiltration works through a positive pressure gradient on the blood side and negative pressure on the fluid side of the hemofilter membrane. Diffusion moves molecules from a high to low concentration area until evenly distributed. Adsorption involves solutes clinging to the membrane, eventually clogging it. CRRT clearance depends on solute size, membrane pore size, and ultrafiltration rate, with small molecules cleared by diffusion and convection, and middle-large molecules primarily by convection. Membranes remove substances up to 50,000 Daltons.
Renal Replacement Therapy: modes and evidenceMohd Saif Khan
This document discusses various modes of renal replacement therapy (RRT) for acute kidney injury (AKI) patients, including their principles, advantages, disadvantages, and evidence regarding optimal dosing. It summarizes that while early RRT initiation and higher RRT doses were associated with better outcomes in some studies, large randomized controlled trials found no significant differences in mortality between early versus late initiation or higher versus lower RRT doses. The optimal RRT modality and timing remains unclear based on current evidence.
This document provides information on continuous renal replacement therapy (CRRT) modalities and dosing. It discusses CRRT principles, indications, modes of therapy including CVVH, CVVHD and CVVHDF. Details are given on vascular access, replacement fluids, anticoagulation options, and monitoring patients on CRRT. Examples show calculations for setting flow rates based on patient weight and condition. Complications of CRRT are outlined. Guidelines recommend CRRT for hemodynamically unstable acute kidney injury patients.
This document discusses different types of continuous renal replacement therapy (CRRT), including CVVH, CVVHD, and CVVHDF. CRRT is indicated for critically ill patients with renal failure and hemodynamic instability or those who need continuous removal of volume or toxins. The procedures, anticoagulation methods, and order examples for each modality are provided. Standard heparin, low molecular weight heparin, and regional citrate anticoagulation are compared. CVVH uses hemofiltration, CVVHD uses hemodialysis, and CVVHDF uses a combination of hemofiltration and hemodialysis for renal replacement in critically ill patients.
This document provides an overview of intensive care nephrology, including acute kidney injury (AKI), indications for acute dialysis, complications of dialysis, and management of certain drug overdoses. It defines AKI as an acute decrease in glomerular filtration rate (GFR) and loss of small solute clearance. Staging criteria for AKI like RIFLE are discussed. Biomarkers for early detection of AKI like neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C are presented. Indications for renal replacement therapy in AKI, management of hyperkalemia, and use of bicarbonate, insulin, and salbutamol for hyperkal
1. Extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) are important life support therapies used in intensive care units.
2. ECMO uses an external circuit to oxygenate blood and remove carbon dioxide, functioning as a bridge to recovery, transplant, or decision. CRRT slowly removes waste and fluid from the blood of patients with kidney failure or injury.
3. The document discusses the principles, indications, techniques, and complications of ECMO and CRRT, highlighting their roles in supporting critically ill patients with cardiac, respiratory, or renal issues.
This document discusses the principles and molecular transport mechanisms of continuous renal replacement therapy (CRRT), including ultrafiltration, diffusion, convection, and adsorption. Ultrafiltration works through a positive pressure gradient on the blood side and negative pressure on the fluid side of the hemofilter membrane. Diffusion moves molecules from a high to low concentration area until evenly distributed. Adsorption involves solutes clinging to the membrane, eventually clogging it. CRRT clearance depends on solute size, membrane pore size, and ultrafiltration rate, with small molecules cleared by diffusion and convection, and middle-large molecules primarily by convection. Membranes remove substances up to 50,000 Daltons.
Renal Replacement Therapy: modes and evidenceMohd Saif Khan
This document discusses various modes of renal replacement therapy (RRT) for acute kidney injury (AKI) patients, including their principles, advantages, disadvantages, and evidence regarding optimal dosing. It summarizes that while early RRT initiation and higher RRT doses were associated with better outcomes in some studies, large randomized controlled trials found no significant differences in mortality between early versus late initiation or higher versus lower RRT doses. The optimal RRT modality and timing remains unclear based on current evidence.
This document provides information on continuous renal replacement therapy (CRRT) modalities and dosing. It discusses CRRT principles, indications, modes of therapy including CVVH, CVVHD and CVVHDF. Details are given on vascular access, replacement fluids, anticoagulation options, and monitoring patients on CRRT. Examples show calculations for setting flow rates based on patient weight and condition. Complications of CRRT are outlined. Guidelines recommend CRRT for hemodynamically unstable acute kidney injury patients.
This document discusses different types of continuous renal replacement therapy (CRRT), including CVVH, CVVHD, and CVVHDF. CRRT is indicated for critically ill patients with renal failure and hemodynamic instability or those who need continuous removal of volume or toxins. The procedures, anticoagulation methods, and order examples for each modality are provided. Standard heparin, low molecular weight heparin, and regional citrate anticoagulation are compared. CVVH uses hemofiltration, CVVHD uses hemodialysis, and CVVHDF uses a combination of hemofiltration and hemodialysis for renal replacement in critically ill patients.
This document provides an overview of intensive care nephrology, including acute kidney injury (AKI), indications for acute dialysis, complications of dialysis, and management of certain drug overdoses. It defines AKI as an acute decrease in glomerular filtration rate (GFR) and loss of small solute clearance. Staging criteria for AKI like RIFLE are discussed. Biomarkers for early detection of AKI like neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C are presented. Indications for renal replacement therapy in AKI, management of hyperkalemia, and use of bicarbonate, insulin, and salbutamol for hyperkal
CRRT describes a group of renal replacement therapies that provide continuous renal replacement over an extended period of time, typically 24 hours per day. There are several CRRT modalities including CVVH, CVVHD, and CVVHDF that utilize different molecular transport mechanisms like diffusion, convection, and ultrafiltration. CRRT is commonly used to treat acute kidney injury as it closely mimics the native kidney and is better tolerated by hemodynamically unstable patients. Studies have shown that earlier initiation of CRRT and achieving an adequate dose of effluent flow rate or solute clearance may improve survival rates in patients with acute renal failure.
The document outlines the objectives and key concepts of a training course on continuous renal replacement therapy (CRRT). It defines CRRT and discusses the basic principles of CRRT, including solute transport mechanisms, clinical indications, machine setup and safety features, and fluid balance principles. It also summarizes evidenced-based research showing improved patient survival with early CRRT initiation and adequate dose delivery.
CRRT and AKI
- Continuous renal replacement therapy (CRRT) is a treatment for acute kidney injury (AKI) that can remove fluid and waste products from patients who are hemodynamically unstable.
- CRRT was developed in the 1970s-1980s and uses an extracorporeal blood pump and catheter to continuously filter blood outside the body.
- The choice of CRRT or intermittent dialysis depends on the patient's condition and stability, with CRRT often preferred for unstable patients with fluid overload or brain injury.
- Proper nursing management before, during, and after CRRT is crucial and includes assessments, monitoring, preventing mechanical issues, and managing antico
A very simple yet comprehensive presentation to understand the concept of CRRT and its implementation in Intensive Care Unit. Intended for the very beginners in ICU. After going through the presentation you will be able to say "Now I know it!"
CRRT (continuous renal replacement therapy) involves using an extracorporeal circuit connected to the patient via catheters to slowly remove fluid and toxins over 24 hours, mimicking the function of the kidneys. It was developed for critically ill patients who cannot tolerate the fluid shifts of intermittent hemodialysis. CRRT uses a semipermeable membrane to filter fluids and small molecules from the blood based on hydrostatic pressure gradients. It provides more hemodynamic stability than intermittent hemodialysis and allows for better nutrition support by preventing fluid overload. CRRT is indicated for patients who cannot tolerate intermittent dialysis due to hemodynamic instability from their critical illness.
Complicationsandsafetyduringcpb 180414072601Manu Jacob
This document discusses safety during cardiopulmonary bypass (CPB). It covers several topics:
1. Bypass safety has improved considerably with better safety features and techniques, though fatal accidents occurred in 1/1800 cases and serious incidents in 1/130 procedures in 1981.
2. Organizational aspects emphasize teamwork, cooperation, coordination, and effective communication within the open-heart unit.
3. Protocols should be established for equipment, patient specifics, perfusion management, and handling accidents to maximize safety. Human error is the leading cause of accidents, followed by equipment failures. Constant updates and a focus on safety can help minimize risks.
Dialysis dose prescription (the basics) dr ujjawalUjjawal Roy
The document discusses key aspects of dialysis dose prescription, including:
1) Components of the dialysis prescription include dialyzer choice, time, blood and dialysate flow rates, ultrafiltration rate, dialysate composition, temperature, and anticoagulation.
2) Prescription goals are to restore the body's fluid and electrolyte balance and remove waste and excess water from patients with end-stage renal disease.
3) Important considerations for dialysis prescription include a patient's dry weight and risk of intradialytic hypotension.
Continuous renal replacement therapy (CRRT) involves using extracorporeal blood purification therapies to slowly remove waste and fluid from patients with impaired kidney function over an extended period of time, typically 24 hours per day. CRRT aims to closely mimic the native kidney and is well-tolerated by hemodynamically unstable patients. It allows for gentle removal of large amounts of fluid and waste products while also controlling electrolytes, acid-base balance, and removal of sepsis mediators. CRRT has advantages over intermittent dialysis in managing fluid overload and maintaining hemodynamic stability.
This document provides information about continuous renal replacement therapies (CRRT). It begins by explaining that CRRT is a type of hemodialysis used for critically ill patients with acute or chronic kidney failure. CRRT circulates blood through a filter and slowly removes waste and excess fluid over an extended period, preventing rapid fluid shifts. The document then discusses the different modes of CRRT, including continuous venovenous hemofiltration, hemodialysis, and hemodiafiltration. It covers the principles, processes, equipment, and nursing management of CRRT.
- Renal replacement therapies are important in critical care for managing complications of renal failure such as fluid, electrolyte and acid-base imbalances. There are many questions around optimal therapy including timing, dose and modality.
- Acute kidney injury is common in the ICU and associated with worse outcomes. Continuous renal replacement therapies may provide more stable volume and chemistry control compared to intermittent therapies.
- High volume hemofiltration shows promise for removing inflammatory mediators in sepsis but optimal dose is still unclear. Renal replacement therapies have an important role beyond renal support as blood purification techniques.
This document discusses the use of ECMO (extracorporeal membrane oxygenation) after cardiac surgery. It outlines the indications for ECMO, including post-cardiotomy cardiogenic shock. Different cannulation strategies and their considerations are described. Monitoring patients on ECMO includes ensuring adequate oxygen delivery and preventing complications like bleeding, leg ischemia, and pulmonary edema. Myocardial stunning can lead to left ventricular overdistention, so decompression may be needed. Improving contractility may cause the harlequin phenomenon if lungs are not well ventilated. Outcome data shows a prevalence of 0.5-2.6% for post-cardiac surgery ECMO with in-hospital survival rates of
4.hemo filtration & blood conservation techniqueManu Jacob
This document discusses techniques for hemofiltration, blood conservation, and ultrafiltration during cardiopulmonary bypass. It describes:
1. Ultrafiltration and hemofiltration remove fluid and solutes from the bloodstream using semipermeable membranes to create concentration gradients. This can effectively remove edema and concentrate blood.
2. Modified ultrafiltration after bypass can immediately increase hematocrit, decrease right atrial pressure, and improve organ function and hemostasis.
3. Blood conservation techniques during cardiac surgery aim to reduce blood transfusion needs through measures like autologous donation, cell savers to retrieve shed blood, and minimizing priming volume.
Although large efforts are spent for creating fistula as the primary access, use of Hemodialysis Vascular catheters are still the major access on the first Hemodialysis session and after 4 month whether we would like it or not.
"USRDS 2013"
Complications & troubleshooting in continuous renal replacement therapymansoor masjedi
Acute kidney injury is a common and important issue in critical care patients . Among different extra corporeal supporting modalities , continuous renal replacement therapy is a common selection especially in unstable conditions . As any other intervention , there are some related complications that should be diagnosed and treated as early as possible .
The cardiopulmonary bypass circuit must be primed with fluid to allow adequate blood flow without air embolism risks. Historically, whole blood was used but increased risks. Solutions now use crystalloids like lactated Ringer's or colloids like albumin and hydroxyethyl starch. Acceptable hemodilution is 25-30% hematocrit. Additional components like calcium, steroids, and bicarbonate are sometimes added. Adequacy of perfusion under hemodilution is assessed using measures like EEG, renal function, and blood gases.
This document discusses various aspects of venovenous extracorporeal membrane oxygenation (VV ECMO) cannulation and management. It provides details on different cannulation strategies and their effects on recirculation. Specifically, it notes that femoro-atrial cannulation had significantly less flow requirement compared to atrio-femoral cannulation during VV ECMO. It also discusses techniques to minimize recirculation like using larger dual-lumen cannulae and ultrasound guidance for proper cannula positioning. Monitoring recirculation is important to optimize ECMO efficiency and outcomes.
This document discusses anticoagulation and hemostasis during cardiopulmonary bypass. It covers normal coagulation pathways, the use of heparin for anticoagulation during bypass, and protamine for reversing the effects of heparin afterwards. Complications from heparin like heparin-induced thrombocytopenia and alternatives to heparin and protamine are also reviewed. Maintaining the delicate balance of anticoagulation during bypass and restoring hemostasis afterwards is an important consideration in cardiac surgery.
This document summarizes renal replacement therapy modalities. It discusses that acute kidney injury affects 5% of hospitalized patients and increases mortality. The main renal replacement therapies are hemodialysis, peritoneal dialysis, and continuous renal replacement therapies. Hemodialysis removes water and solutes across a semipermeable membrane via diffusion and convection. Peritoneal dialysis utilizes the peritoneal membrane for solute and fluid removal. Choice of modality depends on patient factors and available resources. The goal of renal replacement therapy is to control fluid, electrolyte, and acid-base disturbances while providing adequate solute clearance.
This document provides an overview of extracorporeal membrane oxygenation (ECMO) including its definition, history, components, configurations, physiology, indications, and complications. ECMO temporarily replaces or supports the cardiopulmonary system by extracting blood, oxygenating it through an artificial lung, then returning it to circulation. Key points include:
- ECMO was developed in the 1960s-70s and can support heart and/or lung function for weeks.
- The circuit includes cannulae, a pump, oxygenator, and controller. Configurations include venovenous (lung support) and venoarterial (heart and lung support).
- ECMO settings impact oxygen delivery and carbon dioxide
CRRT with Prismaflex slides renal replacement.pdfchaser86
Continuous renal replacement therapy (CRRT) modalities include slow continuous ultrafiltration (SCUF), continuous veno-venous hemofiltration (CVVH), continuous veno-venous hemodialysis (CVVHD), and continuous veno-venous hemodiafiltration (CVVHDF). The Prismaflex system provides a user-friendly platform for individualized CRRT prescriptions using various components like filters, solutions, and catheters. Optimal CRRT dosing is recommended at 20-25 ml/kg/hr based on studies showing no significant difference in mortality between high and low intensity doses in that range.
CRRT describes a group of renal replacement therapies that provide continuous renal replacement over an extended period of time, typically 24 hours per day. There are several CRRT modalities including CVVH, CVVHD, and CVVHDF that utilize different molecular transport mechanisms like diffusion, convection, and ultrafiltration. CRRT is commonly used to treat acute kidney injury as it closely mimics the native kidney and is better tolerated by hemodynamically unstable patients. Studies have shown that earlier initiation of CRRT and achieving an adequate dose of effluent flow rate or solute clearance may improve survival rates in patients with acute renal failure.
The document outlines the objectives and key concepts of a training course on continuous renal replacement therapy (CRRT). It defines CRRT and discusses the basic principles of CRRT, including solute transport mechanisms, clinical indications, machine setup and safety features, and fluid balance principles. It also summarizes evidenced-based research showing improved patient survival with early CRRT initiation and adequate dose delivery.
CRRT and AKI
- Continuous renal replacement therapy (CRRT) is a treatment for acute kidney injury (AKI) that can remove fluid and waste products from patients who are hemodynamically unstable.
- CRRT was developed in the 1970s-1980s and uses an extracorporeal blood pump and catheter to continuously filter blood outside the body.
- The choice of CRRT or intermittent dialysis depends on the patient's condition and stability, with CRRT often preferred for unstable patients with fluid overload or brain injury.
- Proper nursing management before, during, and after CRRT is crucial and includes assessments, monitoring, preventing mechanical issues, and managing antico
A very simple yet comprehensive presentation to understand the concept of CRRT and its implementation in Intensive Care Unit. Intended for the very beginners in ICU. After going through the presentation you will be able to say "Now I know it!"
CRRT (continuous renal replacement therapy) involves using an extracorporeal circuit connected to the patient via catheters to slowly remove fluid and toxins over 24 hours, mimicking the function of the kidneys. It was developed for critically ill patients who cannot tolerate the fluid shifts of intermittent hemodialysis. CRRT uses a semipermeable membrane to filter fluids and small molecules from the blood based on hydrostatic pressure gradients. It provides more hemodynamic stability than intermittent hemodialysis and allows for better nutrition support by preventing fluid overload. CRRT is indicated for patients who cannot tolerate intermittent dialysis due to hemodynamic instability from their critical illness.
Complicationsandsafetyduringcpb 180414072601Manu Jacob
This document discusses safety during cardiopulmonary bypass (CPB). It covers several topics:
1. Bypass safety has improved considerably with better safety features and techniques, though fatal accidents occurred in 1/1800 cases and serious incidents in 1/130 procedures in 1981.
2. Organizational aspects emphasize teamwork, cooperation, coordination, and effective communication within the open-heart unit.
3. Protocols should be established for equipment, patient specifics, perfusion management, and handling accidents to maximize safety. Human error is the leading cause of accidents, followed by equipment failures. Constant updates and a focus on safety can help minimize risks.
Dialysis dose prescription (the basics) dr ujjawalUjjawal Roy
The document discusses key aspects of dialysis dose prescription, including:
1) Components of the dialysis prescription include dialyzer choice, time, blood and dialysate flow rates, ultrafiltration rate, dialysate composition, temperature, and anticoagulation.
2) Prescription goals are to restore the body's fluid and electrolyte balance and remove waste and excess water from patients with end-stage renal disease.
3) Important considerations for dialysis prescription include a patient's dry weight and risk of intradialytic hypotension.
Continuous renal replacement therapy (CRRT) involves using extracorporeal blood purification therapies to slowly remove waste and fluid from patients with impaired kidney function over an extended period of time, typically 24 hours per day. CRRT aims to closely mimic the native kidney and is well-tolerated by hemodynamically unstable patients. It allows for gentle removal of large amounts of fluid and waste products while also controlling electrolytes, acid-base balance, and removal of sepsis mediators. CRRT has advantages over intermittent dialysis in managing fluid overload and maintaining hemodynamic stability.
This document provides information about continuous renal replacement therapies (CRRT). It begins by explaining that CRRT is a type of hemodialysis used for critically ill patients with acute or chronic kidney failure. CRRT circulates blood through a filter and slowly removes waste and excess fluid over an extended period, preventing rapid fluid shifts. The document then discusses the different modes of CRRT, including continuous venovenous hemofiltration, hemodialysis, and hemodiafiltration. It covers the principles, processes, equipment, and nursing management of CRRT.
- Renal replacement therapies are important in critical care for managing complications of renal failure such as fluid, electrolyte and acid-base imbalances. There are many questions around optimal therapy including timing, dose and modality.
- Acute kidney injury is common in the ICU and associated with worse outcomes. Continuous renal replacement therapies may provide more stable volume and chemistry control compared to intermittent therapies.
- High volume hemofiltration shows promise for removing inflammatory mediators in sepsis but optimal dose is still unclear. Renal replacement therapies have an important role beyond renal support as blood purification techniques.
This document discusses the use of ECMO (extracorporeal membrane oxygenation) after cardiac surgery. It outlines the indications for ECMO, including post-cardiotomy cardiogenic shock. Different cannulation strategies and their considerations are described. Monitoring patients on ECMO includes ensuring adequate oxygen delivery and preventing complications like bleeding, leg ischemia, and pulmonary edema. Myocardial stunning can lead to left ventricular overdistention, so decompression may be needed. Improving contractility may cause the harlequin phenomenon if lungs are not well ventilated. Outcome data shows a prevalence of 0.5-2.6% for post-cardiac surgery ECMO with in-hospital survival rates of
4.hemo filtration & blood conservation techniqueManu Jacob
This document discusses techniques for hemofiltration, blood conservation, and ultrafiltration during cardiopulmonary bypass. It describes:
1. Ultrafiltration and hemofiltration remove fluid and solutes from the bloodstream using semipermeable membranes to create concentration gradients. This can effectively remove edema and concentrate blood.
2. Modified ultrafiltration after bypass can immediately increase hematocrit, decrease right atrial pressure, and improve organ function and hemostasis.
3. Blood conservation techniques during cardiac surgery aim to reduce blood transfusion needs through measures like autologous donation, cell savers to retrieve shed blood, and minimizing priming volume.
Although large efforts are spent for creating fistula as the primary access, use of Hemodialysis Vascular catheters are still the major access on the first Hemodialysis session and after 4 month whether we would like it or not.
"USRDS 2013"
Complications & troubleshooting in continuous renal replacement therapymansoor masjedi
Acute kidney injury is a common and important issue in critical care patients . Among different extra corporeal supporting modalities , continuous renal replacement therapy is a common selection especially in unstable conditions . As any other intervention , there are some related complications that should be diagnosed and treated as early as possible .
The cardiopulmonary bypass circuit must be primed with fluid to allow adequate blood flow without air embolism risks. Historically, whole blood was used but increased risks. Solutions now use crystalloids like lactated Ringer's or colloids like albumin and hydroxyethyl starch. Acceptable hemodilution is 25-30% hematocrit. Additional components like calcium, steroids, and bicarbonate are sometimes added. Adequacy of perfusion under hemodilution is assessed using measures like EEG, renal function, and blood gases.
This document discusses various aspects of venovenous extracorporeal membrane oxygenation (VV ECMO) cannulation and management. It provides details on different cannulation strategies and their effects on recirculation. Specifically, it notes that femoro-atrial cannulation had significantly less flow requirement compared to atrio-femoral cannulation during VV ECMO. It also discusses techniques to minimize recirculation like using larger dual-lumen cannulae and ultrasound guidance for proper cannula positioning. Monitoring recirculation is important to optimize ECMO efficiency and outcomes.
This document discusses anticoagulation and hemostasis during cardiopulmonary bypass. It covers normal coagulation pathways, the use of heparin for anticoagulation during bypass, and protamine for reversing the effects of heparin afterwards. Complications from heparin like heparin-induced thrombocytopenia and alternatives to heparin and protamine are also reviewed. Maintaining the delicate balance of anticoagulation during bypass and restoring hemostasis afterwards is an important consideration in cardiac surgery.
This document summarizes renal replacement therapy modalities. It discusses that acute kidney injury affects 5% of hospitalized patients and increases mortality. The main renal replacement therapies are hemodialysis, peritoneal dialysis, and continuous renal replacement therapies. Hemodialysis removes water and solutes across a semipermeable membrane via diffusion and convection. Peritoneal dialysis utilizes the peritoneal membrane for solute and fluid removal. Choice of modality depends on patient factors and available resources. The goal of renal replacement therapy is to control fluid, electrolyte, and acid-base disturbances while providing adequate solute clearance.
This document provides an overview of extracorporeal membrane oxygenation (ECMO) including its definition, history, components, configurations, physiology, indications, and complications. ECMO temporarily replaces or supports the cardiopulmonary system by extracting blood, oxygenating it through an artificial lung, then returning it to circulation. Key points include:
- ECMO was developed in the 1960s-70s and can support heart and/or lung function for weeks.
- The circuit includes cannulae, a pump, oxygenator, and controller. Configurations include venovenous (lung support) and venoarterial (heart and lung support).
- ECMO settings impact oxygen delivery and carbon dioxide
CRRT with Prismaflex slides renal replacement.pdfchaser86
Continuous renal replacement therapy (CRRT) modalities include slow continuous ultrafiltration (SCUF), continuous veno-venous hemofiltration (CVVH), continuous veno-venous hemodialysis (CVVHD), and continuous veno-venous hemodiafiltration (CVVHDF). The Prismaflex system provides a user-friendly platform for individualized CRRT prescriptions using various components like filters, solutions, and catheters. Optimal CRRT dosing is recommended at 20-25 ml/kg/hr based on studies showing no significant difference in mortality between high and low intensity doses in that range.
Dialysis various modalities and indices usedAbhay Mange
Dialysis is a process used to remove waste and excess water from the blood of patients with kidney failure. There are various modalities of dialysis including intermittent hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Hemodialysis uses diffusion and ultrafiltration across a semi-permeable membrane in a dialyzer to clean the blood. Proper vascular access and anticoagulation are also important aspects of hemodialysis treatment.
1. The document describes a case of a 28-year-old female with cyanotic congenital heart disease who underwent an arterial switch operation with integrated ECMO support.
2. ECMO is a form of extracorporeal life support used for both cardiac and respiratory failure in adults. It involves pumping blood out of the body to an artificial lung for gas exchange before returning it to circulation.
3. The key components of an ECMO circuit include a blood pump, membrane oxygenator, tubing, heat exchanger, and monitoring equipment. Proper anticoagulation and flow rates are important for safety and effectiveness.
Basic principles of hemodialysis finalFarragBahbah
This document discusses the basic principles of hemodialysis. It covers:
1) Hemodialysis aims to remove waste, correct electrolytes, and remove excess fluids via diffusion, convection, and ultrafiltration across a semi-permeable membrane.
2) Countercurrent blood-dialysate flow maintains the concentration gradient to increase solute removal efficiency.
3) Clearance depends on factors like molecular weight, blood/dialysate flow rates, and dialyzer properties. Higher blood flows and matching dialysate flows can improve clearance.
- ECMO is a form of extracorporeal life support that removes blood from the body, oxygenates it using an artificial lung, then returns it to the body.
- It was first developed in the 1950s and has been increasingly used since the 1970s for conditions like respiratory failure and cardiac failure.
- There are two main types - venovenous ECMO which only supports the lungs, and venoarterial ECMO which also supports the heart.
- ECMO is used as a temporary bridge for patients with severe, potentially reversible conditions while waiting for recovery, a decision on next steps, or an organ transplant.
This document provides an overview of extracorporeal membrane oxygenation (ECMO), including its history, principles, components, indications, and complications. Some key points:
- ECMO is a form of extracorporeal life support that oxygenates blood and removes carbon dioxide outside of the body, then returns the blood to the patient. It has been used since the 1950s and is now standard treatment for some cardiac and respiratory conditions.
- The basic ECMO circuit includes a blood pump, membrane oxygenator, heat exchanger, cannulas, and tubing. There are various configurations depending on whether it is used for respiratory (VV ECMO) or cardiac (VA ECMO) support.
-
Here is a “Medical Product Datasheet Template“. TDSmaker offer you free Datasheet/ Specsheet/ Techsheet. Visit to ( https://www.tdsmaker.com ) to get start with free template.
This document discusses the basics of hemodialysis, including the main principles of diffusion, osmosis, filtration, and convection that hemodialysis is based on. It also describes the technique of hemodialysis, varieties of hemodialysis methods like conventional hemodialysis and online hemodiafiltration, and provides details on assessing hemodialysis treatment adequacy using Kt/V.
This document provides an overview of extracorporeal membrane oxygenation (ECMO), including its history, principles, components, indications, contraindications, mechanisms, and complications. ECMO is a form of extracorporeal life support that oxygenates a patient's blood and removes carbon dioxide before returning it to circulation. It is used as a bridge to recovery, decision, or transplant for patients with severe cardiac or respiratory failure. The document describes the various ECMO circuits and cannulation methods, as well as guidelines for initiation and monitoring of ECMO.
Twelve studies including over 1700 patients on venoarterial ECMO were reviewed. The overall mortality rate was 54% with 45% of deaths occurring during ECMO support and 13% after ECMO was stopped. Common complications included renal failure in 52% of patients, pneumonia in 33%, bleeding in 33%, oxygenator dysfunction requiring replacement in 29%, and sepsis in 26%. Proper anticoagulation and cannula management are important to prevent complications such as bleeding, thrombosis, and limb ischemia, which remain the most significant issues related to VA-ECMO use. Hypoxemia can also occur if cardiac function recovers enough to eject blood through the lungs while they remain impaired.
Renal replacement therapy is used to remove waste and fluid when kidney function is severely impaired and life is at risk. There are four main forms: hemodialysis, hemofiltration, peritoneal dialysis, and hemodiafiltration. Hemodialysis involves removing blood from the body, passing it through a dialyzer to filter out waste and fluid before returning it. Hemofiltration is similar but uses convection rather than diffusion and does not require dialysate. Peritoneal dialysis infuses fluid into the abdomen to draw out waste. Hemodiafiltration combines hemodialysis and hemofiltration for enhanced waste and fluid control.
1) Hemodialysis and CRRT are renal replacement therapies used to treat acute kidney injury by removing waste and fluid from the blood. CRRT provides more gradual and continuous treatment compared to intermittent hemodialysis.
2) Indications for RRT include fluid overload, hyperkalemia, acidosis, rising urea/creatinine, uraemia symptoms, and sepsis. The choice of RRT depends on what needs to be removed, the patient's stability, resources, and clinical factors.
3) CRRT modalities include CVVH, CVVHD, and CVVHDF. Anticoagulation is usually needed but can be avoided if the patient is already coagulo
1) ECMO and ECCO2R are being re-examined as alternatives to invasive mechanical ventilation for critically ill patients, as the technologies have improved.
2) Specifically, ECMO is being used instead of mechanical ventilation for some patients awaiting lung transplantation, with promising results.
3) While ECMO and ECCO2R may help reduce ventilator-induced lung injury and duration of mechanical ventilation, more research is still needed to determine if they can fully replace invasive mechanical ventilation.
This document provides an overview of basic principles of liver resection, including:
- A brief history of liver resection and techniques like hepatic inflow occlusion.
- Concepts of liver regeneration, surgical anatomy, and terminology as described by Couinaud.
- Surgical techniques for liver transection including finger fracture, water jet, CUSA, Ligasure, and vascular staplers.
- Methods of vascular control during resection like Pringle maneuver, liver hanging maneuver, and total hepatic vascular exclusion.
- Postoperative management considerations like fluid/electrolyte balance, nutrition, pain control, and monitoring for liver failure.
This document provides an overview of plasmapheresis, a therapeutic procedure that involves removing macromolecules from a patient's plasma. It discusses the history of plasmapheresis and how it works to separate plasma from blood cells. Common indications for plasmapheresis include renal and non-renal diseases. Technical aspects such as plasma separation techniques, anticoagulants, replacement fluids, and venous access are also summarized.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Ecmo crrt
1. 2,800+
OPEN ACCESS BOOKS
97,000+
INTERNATIONAL
AUTHORS AND EDITORS
90+ MILLION
DOWNLOADS
BOOKS
DELIVERED TO
151 COUNTRIES
AUTHORS AMONG
TOP 1%
MOST CITED SCIENTIST
12.2%
AUTHORS AND EDITORS
FROM TOP 500 UNIVERSITIES
Selection of our books indexed in the
Book Citation Index in Web of Science™
Core Collection (BKCI)
Chapter from the book Extracorporeal Membrane Oxygenation - Advances in Therapy
Downloaded from: http://www.intechopen.com/books/extracorporeal-membrane-
oxygenation-advances-in-therapy
PUBLISHED BY
World's largest Science,
Technology & Medicine
Open Access book publisher
Interested inpublishing withInTechOpen?
Contact us at book.department@intechopen.com
3. 1. Introduction
Extracorporeal membrane oxygenation (ECMO) is a modality of treatment used in the inten‐
sivecareunit(ICU)toimprovegasexchangeinpatientswithlife-threateningrespiratoryfailure
and when conventional therapeutic methods fail to sustain sufficient oxygenation and/or the
removal of carbon dioxide. Renal replacement therapy (RRT) is added to the ECMO for the
treatment ofacid-baseaswellaselectrolyteimbalance andfluidoverload.Thischapteristrying
to discuss the current state and role of renal replacement therapy in patients on ECMO and
address the controversies and challenges about its application.
2. Continuous renal replacement therapy
Continuous renal replacement therapy (CRRT) is the mode of therapy adopted in patients with
hemodynamic instability in whom intermittent hemodialysis cannot control volume or
metabolic derangements. The concept of CRRT was introduced in 1980 and was used mainly
for management of critically ill patients with acute kidney injury (AKI). The better hemody‐
namic tolerance seen in CRRT is due to slower solute clearance and removal of fluid per unit
of time. CRRT works on the principle of convection and diffusion. In regular hemodialysis,
diffusion is the modality of solute movement and ultrafiltration is added to the process for the
purpose of fluid removal. One of the major disadvantages of conventional hemodialysis is that
it is done only for limited amount of time, and hence it is difficult to achieve adequate fluid
removal in patients who have hemodynamic instability. Moreover, critically ill patients receive
large amounts of fluid and in the presence of reduced renal function keeping the fluid balance
is a challenge. Hence, CRRT treatment is appropriate for patients with hemodynamic insta‐
bility, fluid overload, catabolism, or sepsis with acute kidney injury (AKI) [1].
The usual CRRT circuit involves a double lumen catheter, tubing to carry blood from patient’s
body through the catheter to the CRRT machine, CRRT machine and return tubing which sends
the blood back to the patient's body. There are three different modes of doing CRRT: contin‐
uous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD),
and continuous venovenous hemodiafiltration (CVVHDF). CVVHD works on the principle of
diffusion and hence it is inefficient in terms of removal of large molecular weight substances.
On the other hand, CVVH works on the principle of convection, which is the movement of
water along with electrolytes, and CVVHDF employs both diffusion and convection. Convec‐
tion is dependent on the pressure and pore size of the membrane. Perfusion pressure generated
by a peristaltic pump drives the ultrafiltration of plasma across a biosynthetic hemofiltration
membrane. In this process, a high ultrafiltration rate is required to achieve convective clearance
and hence replacement fluid must be added to the extracorporeal circuit to restore fluid volume
and electrolytes [1].
The solution bags used for doing CRRT contains glucose and electrolytes (including sodium,
potassium, calcium, and magnesium) in concentrations that are in the physiologic range. The
dose of CRRT is decided based on effluent dose. It is defined as the flow of effluent in ml/kg/
Extracorporeal Membrane Oxygenation: Advances in Therapy344
4. hr. Based on clinical studies, the recommended effluent dose is 20–25 ml/kg/hr. But at the same
time, solute clearance will be affected by clotting and protein deposition on the hemofilter
membrane. Anticoagulants are also added to the circuit for the sake of keeping the filter patent
for a longer period and usual anticoagulants used include citrate and heparin. The usual blood
flow rates on CRRT circuit range 150–250 cc/min.
Although CVVHDF is preferred over CVVH in most institutions, there is no one modality,
which is shown to be superior over the other. There might be a theoretical advantage for CVVH
and CVVHD in terms of removing larger molecules like cytokines in septic patients. But at the
same time, relevant clinical studies have not shown any benefit in terms of improvement in
plasma concentration of cytokines or outcome.
3. Technical aspects of combining ECMO and CRRT
There are a number of ways CRRT can be initiated in a patient undergoing treatment with
ECMO. The most common technique is using separate vascular access and circuit for CRRT
and ECMO. This technique ensures that both systems do not interfere with each other’s
hemodynamics. One of the disadvantages with this connection is the introduction of a large
cannula while the patient is on anticoagulation which increases the risk of bleeding compli‐
cations at the time of insertion. Additionally in some cases, multiple vascular access sites might
be required for doing ECMO which will limit the number of access sites available for estab‐
lishing CRRT circuit.
Another method is by introducing the CRRT machine or a hemofilter into the ECMO circuit
otherwise called as inline technique. Here blood for the CRRT circuit is accessed from and
returned to ECMO circuit. Inlet to the CRRT circuit can be before or after the oxygenator or
centrifugal pump. Similarly, venous return from CRRT circuit is connected to ECMO circuit
before or after the oxygenator or centrifugal pump. In ECMO circuits, using roller pump, a
similar setting can be established. Inline hemofilter is used in conditions where the goal is only
to remove the fluid and not solutes. The different inline ECMO/CRRT/hemofilter connections
are depicted in Figures 1–5. Advantages of incorporating the CRRT circuit into the ECMO
circuit include (1) cost effectiveness, (2) easy to set up the circuit, (3) use of low blood volume,
(4) ease of operability, (5) less resource intensive, (6) avoid additional access placement and
ensuing complications especially in the background of anticoagulation use, and (7) the
oxygenator in the ECMO circuit can work as an air bubble and blood clot trap for both the
ECMO and CRRT circuit (provided both inlet and outlet lines are connected to the ECMO
circuit before the oxygenator or to the oxygenator). One of the major disadvantages of
incorporating the CRRT circuit into the ECMO line is the interference of blood flow in the
CRRT as well as the ECMO circuit. If the CRRT machine’s venous (outlet) line is connected to
the ECMO circuit before the centrifuge pump, purified blood from the CRRT returns into the
negative pressure part of the ECMO circuit. This generates low return pressure alarm in the
CRRT machine which may subsequently shut down the machine. The connection of arterial
line post pump can trigger too high pressure on the arterial access side of the CRRT generating
alarms inside the CRRT machine. Conversely, connections with arterial line pre-pump and
Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
http://dx.doi.org/10.5772/64164
345
5. venous line post-pump can trigger low-pressure arterial (access) alarms and high-pressure
return (venous) alarms in the CRRT circuit, respectively. These can interfere with pressure
monitoring within the CRRT filter reducing the lifespan of the filter. Moreover, the drastic
difference in flow and pressure will increase shear stress, activate the clotting cascade and
release noxious cytokines. This, in turn, can predispose to the potential life-threatening
hemolysis, disseminated intravascular coagulation and enhanced systemic inflammation. The
hemolysis through the medium of hemoglobinuria can precipitate renal injury [2, 3].
Figure 1. ECMO-CRRT connection with inlet of the CRRT circuit connected to the inlet line of ECMO circuit precentri‐
fugal pump and outlet of the CRRT circuit to the ECMO circuit postcentrifugal pump.
Figure 2. ECMO-CRRT connection with inlet of the CRRT circuit connected to ECMO circuit postcentrifugal pump and
outlet of the CRRT circuit to the ECMO circuit precentrifugal pump.
Extracorporeal Membrane Oxygenation: Advances in Therapy346
6. Figure 3. ECMO-CRRT connection with inlet and outlet of the CRRT circuit connected to ECMO oxygenator.
Figure 4. ECMO-CRRT connection with inlet of the CRRT circuit connected to ECMO circuit postoxygenator and out‐
let of the CRRT circuit to the ECMO circuit precentrifugal pump.
Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
http://dx.doi.org/10.5772/64164
347
7. Figure 5. ECMO-hemofilter connection in an ECMO machine with centrifugal pump. The inlet of the hemofilter circuit
is connected to ECMO circuit postcentrifugal pump and the outlet of the hemofilter circuit is connected to the ECMO
circuit precentrifugal pump.
The flow of blood from and into the ECMO circuit can interfere with blood flow in the ECMO
circuit. The support for a patient with severe hypoxemia often requires high blood flow with
a pump speed of above 3000 rpm and the flow of blood into CRRT circuit may generate very
low pressure particularly when the inflow to the ECMO circuit is limited. This may have
clinical consequences in patients with severe hypoxemia where even small fluctuations in the
ECMO flow can lead to significant drop in the arterial blood oxygenation [2, 3].
4. Indications and benefits of combined ECMO-CRRT treatment
Classic indications for initiation of renal replacement therapy in patients on ECMO include
uremia, acidosis, electrolyte abnormalities, and fluid overload. The most frequently reported
indications were fluid overload (43%), prevention of fluid overload (16%), AKI (35%), elec‐
trolyte disturbances (4%), and other (2%). Combined use of ECMO and CRRT has many
benefits. ECMO by itself is an effective means of providing cardiorespiratory support for these
patients. Similarly, provision of ECMO support may prevent the myocardial damage that can
be caused by inotropic agents or hypoxia and promote hasty recovery of myocardial function.
Both these factors can improve oxygenation and perfusion of organs including the kidneys
which in turn may promote early recovery of renal failure. Correction of hypoxia using the
ECMO machine can result in the reduction of lactic acidosis. The addition of CRRT (with
bicarbonate-based solutions) efficiently manages severe lactic acidosis avoiding fluid overload
Extracorporeal Membrane Oxygenation: Advances in Therapy348
8. and hypocalcemia in hemodynamically unstable patients. Hence combining ECMO with
CRRT might result in rapid reversal of the metabolic sequelae of lactic acidosis [4–6].
Another major advantage of combining CRRT with ECMO is the establishment of favorable
volume status. Improvement in fluid overload or improving fluid balance has been found to
be associated with improved lung function, faster recovery of left ventricular function, better
diastolic compliance, better contractility and less myocardial edema and time to weaning off
ECMO and ventilator support. In addition to the above-mentioned advantages, initiation of
renal replacement therapy (RRT) also allows for the administration of adequate nutrition,
medications, and blood products, while avoiding further fluid accumulation. It can correct
azotemia, electrolyte imbalance and decrease levels of inflammatory cytokines as well as
systemic inflammatory response syndrome induced by ECMO. The latter might be beneficial
in terms of decreasing ECMO-induced renal injury [4–6].
5. Timing of initiation of CRRT in ECMO patients
The timing of initiation of CRRT on ECMO is not well defined. Clinical studies have shown a
beneficial role of early initiation of CRRT and better outcomes in patients on ECMO. The
benefits of early initiation of CRRT in these studies were mostly related to maintenance of fluid
balance. Excessive fluid has been found to be associated with prolonged ECMO duration,
mechanical ventilation, longer length of stay in the ICU, and mortality. CRRT is an important
tool for managing fluid overload in these patients since it enables goal-directed maintenance
of fluid balance. Hence, early initiation of CRRT before the onset of fluid overload should be
considered in patients on ECMO. Blijdorp et al. observed that initiating preemptive CRRT
during ECMO in neonatal patients improved outcomes by decreasing time on ECMO due to
improved fluid management [6, 7]. It has also been shown that odds ratio for death was higher
when CRRT was started later and longer it was performed.
6. Complications of ECMO and CRRT
Complications of CRRT are related to placement of vascular access, cardiac arrhythmias,
electrolyte disturbances, nutrient losses, hypothermia, and bleeding complications from
anticoagulation. Common vascular access-related complications include arterial puncture,
hematoma, hemothorax, pneumothorax, formation of arteriovenous fistulas, aneurysms,
thrombus formation, pericardial tamponade, and retroperitoneal hemorrhage. Electrolyte
imbalances commonly encountered include hypokalemia and hypophosphatemia, which may
lead to complications such as hemolysis and rhabdomyolysis. In unstable patients with
multiple organ failures and fluid overload, although ECMO alone can improve hemodynamic
stability by increasing cardiac output via an ECMO pump (in venoarterial ECMO) and
improved myocardial oxygenation, the presence of fluid overload can nullify these advantag‐
es. Hence, maintenance of fluid balance is very essential in the treatment of critically ill patients
Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
http://dx.doi.org/10.5772/64164
349
9. supported with ECMO and CRRT. Experimental and observational data have shown that
ECMO itself can have hemodynamic consequences and can interfere with the accurate
assessment of volume status. Traditional markers of volume assessment like CVP can be
unreliable in these patients. Larsson et al. in his experiments in swine model showed that
venoarterial ECMO can decrease systemic venous pressure while maintaining systemic
perfusion leading to diminution of central venous pressure measurement [8]. Additionally,
volume assessment can be made difficult by the myocardial dysfunction secondary to use of
ECMO. Numerous mechanisms have been proposed for the pathogenesis of this phenomenon
including low ionized calcium at the onset of cardiac bypass, effect of reactive oxygen species,
toxic substances related to the ECMO circuit, various cytokines involved in inflammation
during ECMO on the myocardium, retrograde nonpulsatile blood flow, particularly, in the
background of underlying left ventricular dysfunction, coronary hypoxia due to higher
oxyhemoglobin saturation in the lower extremities compared to upper body (exclusively seen
with use of femoral arterial catheter placement in a VA ECMO configuration), and increase in
left ventricular afterload. ECMO can additionally result in cardiac stunning as reported by
Martin et al. [9]. Pyles et al. [10] in their experiment on Dorset lambs found that initiation of
ECMO is associated with decreased hemodynamic and echocardiographic measures of LV
function despite accounting for changes in afterload.
The incidence of AKI in patients on ECMO is estimated to be up to 70%. AKI with the need
for renal replacement therapy (RRT) occurs in 50% of patients on ECMO and it is one of the
most frequent additional organ failures in this patient population. ECMO initiation by itself
can lead to acute kidney injury; the mechanisms include ischemia/reperfusion injury from
rapid hemodynamic fluctuation in renal blood flow secondary to adjustments in vasopressors
or inotropes, pigment nephropathy due to hemoglobinuria resulting from hemolysis secon‐
dary to exposure of blood to artificial surfaces, nonpulsatile retrograde renal perfusion,
activation of complement system, and accumulation of cytokines. Development of renal failure
is a reflection of progression to multisystem organ failure. Moreover, it can predispose to the
accumulation of fluid and subsequent volume overload worsening heart and lung disease.
7. Renal recovery and combined ECMO-CRRT
Renal recovery outcome data are limited in patients who have received ECMO and CRRT.
Paden et al. [11] in his study of 154 patients on ECMO and CRRT showed that renal recovery
was seen in 96% of the patients who survived. Similarly, Meyer et al. [12] in a series of neonatal
and pediatric survivors renal recovery was seen in 14/15 (93%) patients. In the study by
Thajudeen et al., the renal recovery was found in all patients who survived. In his study, a key
observation was that all those patients who had renal recovery were on VA ECMO and they
hypothesized that the increased oxygen supply to renal vessels due to its close proximity to
heart in the cases of VA ECMO might have played a role in the renal recovery [13]. All these
studies show a favorable renal outcome in patients who survive.
Extracorporeal Membrane Oxygenation: Advances in Therapy350
10. 8. Mortality in patients on combined ECMO and CRRT
Clinical studies have shown the association between ECMO, CRRT, and high mortality. In a
retrospective study of 200 patients who underwent ECMO 60% (120/200) required renal
replacement therapy (RRT) for AKI and the survival of patients requiring RRT was only 17%.
Wu et al. [14] made a similar observation where the need for RRT was found to be an inde‐
pendent risk factor for mortality. Although survival in ECMO patients has improved tremen‐
dously over the years, the addition of CRRT portends a worse prognosis eliminating this
advantage. Severity of illness has been suggested as a cause of high mortality in these patients.
It is also speculated that in the presence of multiple organ dysfunction syndromes (MODS),
the presence of AKI itself rather than the requirement for CRRT is the independent risk factor
for mortality in critically ill patients undergoing ECMO.
There are data supporting an association between delayed start of CRRT and mortality.
Kielstein et al. [15] observed that the 90-day survival of patients on ECMO needing CRRT was
only 17%; however, at the same time they found that the cohort of patients who had delayed
the start of CRRT had higher mortality. Randomized controlled studies comparing early vs.
late initiation of CRRT before and after the occurrence of the fluid overload in patients on
ECMO would be needed to further address this issue.
9. Antibiotic dosing in CRRT and ECMO
While ECMO and CRRT are important modes of therapy that can sustain life, little is known
about the independent effects of ECMO and CRRT on antibiotic pharmacokinetics. Clear data
on the dosing of medications are lacking at this point. Patients on extracorporeal circuit usually
will have increased volume of distribution and variable clearance. Clinical studies have shown
significant alterations in the pharmacokinetics which can result in suboptimal dosing of
medications (both under- and overdosing). Inadequate or underdoing of antibiotics can lead
to inadequate treatment of sepsis and subsequent increase in morbidity and mortality.
Similarly, too high dosing can lead to systemic toxicity. This is significant in these patients who
already have high infection-related mortality. Guidelines for dosing of medications should
take into consideration the mode of RRT, dose of RRT delivered, blood flow rate, filter material,
and surface area of the filter [16–18].
Author details
Bijin Thajudeen*
, Sepehr Daheshpour and Babitha Bijin
*Address all correspondence to: bijint@gmail.com
Department of Nephrology, Banner University of Arizona Medical Center, Tucson, AZ,
United States
Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
http://dx.doi.org/10.5772/64164
351
11. References
[1] Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J
Med. 2012;367(26): 2505–2514.
[2] Santiago MJ, Sánchez A, López-Herce J, et al. The use of continuous renal replacement
therapy in series with extracorporeal membrane oxygenation. Kidney Int. 2009;76(12):
1289–1292.
[3] Seczyńska B, Królikowski W, Nowak I, Jankowski M, Szułdrzyński K, Szczeklik W.
Continuous renal replacement therapy during extracorporeal membrane oxygenation
in patients treated in medical intensive care unit: technical considerations. Ther Apher
Dial. 2014;18(6): 523–534.
[4] Chen H, Yu RG, Yin NN, Zhou JX. Combination of extracorporeal membrane oxygen‐
ation and continuous renal replacement therapy in critically ill patients: a systematic
review. Crit Care. 2014;18(6): 675.
[5] Jacobs R, Honore PM, Spapen HD. Intertwining extracorporeal membrane oxygenation
and continuous renal replacement therapy: sense or nonsense? Crit Care 2015;19: 145.
[6] Schmidt M, Bailey M, Kelly J, et al. Impact of fluid balance on outcome of adult patients
treated with extracorporeal membrane oxygenation. Intensive Care Med. 2014;40(9):
1256–1266.
[7] Blijdorp K, Cransberg K, Wildschut ED, et al. Haemofiltration in newborns treated with
extracorporeal membrane oxygenation: a case-comparison study. Crit Care. 2009;13(2):
R48.
[8] Larsson M, Talving P, Palmér K, Frenckner B, Riddez L, Broomé M. Experimental
extracorporeal membrane oxygenation reduces central venous pressure: an adjunct to
control of venous hemorrhage? Perfusion. 2010;25(4): 217–223.
[9] Martin GR, Short BL, Abbott C, O'Brien AM. Cardiac stun in infants undergoing
extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 1991;101(4): 607–611.
[10] Pyles LA, Gustafson RA, Fortney J, Einzig S. Extracorporeal membrane oxygenation
induced cardiac dysfunction in newborn lambs. J Cardiovasc Transl Res. 2010;3(6): 625–
634.
[11] Paden ML, Warshaw BL, Heard ML, Fortenberry JD. Recovery of renal function and
survival after continuous renal replacement therapy during extracorporeal membrane
oxygenation. Pediatr Crit Care Med. 2011;12(2): 153–158.
[12] Meyer RJ, Brophy PD, Bunchman TE, et al. Survival and renal function in pediatric
patients following extracorporeal life support with hemofiltration. Pediatr Crit Care
Med. 2001;2(3): 238–242.
Extracorporeal Membrane Oxygenation: Advances in Therapy352
12. [13] Thajudeen B, Kamel M, Arumugam C, et al. Outcome of patients on combined
extracorporeal membrane oxygenation and continuous renal replacement therapy: a
retrospective study. Int J Artif Organs. 2015;38(3): 133–137.
[14] Wu MY, Lin PJ, Tsai FC, Haung YK, Liu KS. Impact of preexisting organ dysfunction
on extracorporeal life support for non-postcardiotomy cardiopulmonary failure.
Resuscitation. 2008;79(1): 54–60.
[15] Kielstein JT, Heiden AM, Beutel G, et al. Renal function and survival in 200 patients
undergoing ECMO therapy. Nephrol Dial Transplant. 2013;28(1): 86–90.
[16] Hites M, Dell'Anna AM, Scolletta S, Taccone FS. The challenges of multiple organ
dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill
patients. Adv Drug Deliv Rev 2014;77: 12–21.
[17] Jamal JA, Economou CJ, Lipman J, Roberts JA. Improving antibiotic dosing in special
situations in the ICU: burns, renal replacement therapy and extracorporeal membrane
oxygenation. Curr Opin Crit Care. 2012;18(5): 460–471.
[18] Shekar K, Fraser JF, Taccone FS, et al. The combined effects of extracorporeal membrane
oxygenation and renal replacement therapy on meropenem pharmacokinetics: a
matched cohort study. Crit Care. 2014;18(6): 565.
Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
http://dx.doi.org/10.5772/64164
353